Impact in Quality of Care of the "STructural heARt NURSE" as New Interventional Cardiology Nursing Role in Spain.

NCT ID: NCT04301648

Last Updated: 2020-03-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

86 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-01

Study Completion Date

2022-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The hypothesis is that patients with structural heart disease who are treated by STructural heARt nurses obtain better results in indicators of quality of care, compared with the usual practice (or not assisted) by this type of new interventional cardiology's nursing role.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Valvular disease is the future epidemic structural heart disease of developed countries. To slow or alter the course of the disease, cardiac valve repair or replacement is necessary. Transcatheter treatment has become a safe alternative to surgery. The United States and Canada developed the TAVI (Transcather Aortic Valve Implantation) program and TAVI Nurse is strongly supported by scientific societies as a key leadership role in the aortic stenosis care process. This nursing role is not implemented in Spain.

The objective of this study is to develop a new nursing role in interventional cardiology, similar to TAVI Nurse but including all the structural heart diseases, through conceptual definition and competencies, and evaluate its impact on the quality of care after of its implementation.

The new nursing role of a hemodynamics and interventional cardiology unit in Spain will be based on the model existing in other countries.

This study consists of three phases:

Phase I) Integrative review to explore and identify the definition and competencies of TAVI Nurse or another similar figure outside Spain, as well as identify quality of care indicators.

Phase II) The competences of these nurses will be contextualized in Spain, and indicators of quality of care will be defined through the consensus of experts using a Delphi methodology.

Phase III) Quasi-experimental pre / post study to assess the quality of care, through the indicators developed, of the implementation of the new nursing role.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Valvular Heart Disease Nurse's Role Competence Cardiac Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Quasi-experimental design study, pre-post intervention type.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Common Practice

Patients included in the phase before will receive common practice.

Group Type ACTIVE_COMPARATOR

Common Practice

Intervention Type OTHER

Common practice will consist in that the nurse who is in the hemodynamic nurse's office will do her usual task that is exclusively health education.

STAR Nurse

Patients included in the phase after will receive care by a STAR Nurse.

Group Type EXPERIMENTAL

STAR Nurse

Intervention Type OTHER

This intervention will consist in that the nurse who is in the hemodynamic nurse's office will do the STAR Nurse's tasks and competences.

Although the intervention will be detailed through phase 1 (integrative review) and 2 (Delphy methodology).

It is expected that the main STAR nurse's competencies and tasks in the nurse's office will be:

1. To guarantee a comprehensive evaluation and appropriate triage to candidates for an interventional procedure of structural heart disease, coordinating the request for complementary tests and previous visits.
2. Make education to the patient and family.
3. Make communication bridge with cardiologists.
4. Establish specific patient-centered care processes.
5. Promote continuity of care after discharge, follow up after discharge, and reevaluate quality of life and fragility.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

STAR Nurse

This intervention will consist in that the nurse who is in the hemodynamic nurse's office will do the STAR Nurse's tasks and competences.

Although the intervention will be detailed through phase 1 (integrative review) and 2 (Delphy methodology).

It is expected that the main STAR nurse's competencies and tasks in the nurse's office will be:

1. To guarantee a comprehensive evaluation and appropriate triage to candidates for an interventional procedure of structural heart disease, coordinating the request for complementary tests and previous visits.
2. Make education to the patient and family.
3. Make communication bridge with cardiologists.
4. Establish specific patient-centered care processes.
5. Promote continuity of care after discharge, follow up after discharge, and reevaluate quality of life and fragility.

Intervention Type OTHER

Common Practice

Common practice will consist in that the nurse who is in the hemodynamic nurse's office will do her usual task that is exclusively health education.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients (\>18 years) who have been or will undergo any procedure of structural heart disease in the hemodynamic and interventional cardiology unit of the Hospital de la Santa Creu i Sant Pau.
* Patients who accept to participate in the study.

Exclusion Criteria

* Patients with cognitive impairment, mental disability or other serious difficulty communicating.
* Patients with insufficient fluency of the main languages.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

FGS Hospital de la Santa Creu i Sant Pau

Barcelona, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

ADRIAN MARQUEZ LOPEZ

Role: CONTACT

+342919000 ext. 7926

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IIBSP-STA-2019-123

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.